|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not
intended to be used as a source of information on on healthcare or medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines
or the package leaflet of your medicine. For up-to-date information on other
healthcare topics, please consult the relevant reliable sources or an healthcare
expert, such as a physician etc.
|
BACK TO LIST |
European Patient Summary
|
|
|
|||||||||||||||||||
Problem list
| Condition | Onset Date | Status |
|---|---|---|
| Chronic kidney disease stage 4 | 20-Apr-2024 | active |
| Anemia | 15-Jul-2023 | active |
| Chronic kidney disease stage 3 | 26-Sep-2015 | active |
| Proteinuria due to type 2 diabetes mellitus | 26-Sep-2015 | active |
| Acute ST segment elevation myocardial infarction | 17-Apr-2013 | active |
| Ischemic heart disease | 22-Jul-2000 | active |
| Chronic kidney disease stage 2 | 06-Jul-1991 | active |
| Microalbuminuria due to type 2 diabetes mellitus | 06-Jul-1991 | active |
| Disorder of kidney due to diabetes mellitus | 08-Sep-1984 | active |
| Chronic kidney disease stage 1 | 08-Sep-1984 | active |
| Essential hypertension | 08-Jun-1968 | active |
Medication list
| No known medications |
Immunizations list
| Vaccine | Date |
|---|---|
| Influenza virus antigen only vaccine product | 26-Apr-2025 |
| SARS-CoV-2 mRNA vaccine | 21-Aug-2021 |
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 13-Oct-2018 |
Procedure History list
| Procedure | Date | Reason |
|---|---|---|
| Depression screening | 17-Jun-2023 | - |
| Assessment of health and social care needs | 17-Jun-2023 | - |
| Assessment of anxiety | 17-Jun-2023 | - |
| Screening for drug abuse | 17-Jun-2023 | - |
| Assessment using Morse Fall Scale | 17-Jun-2023 | - |
| Assessment of substance use | 17-Jun-2023 | - |
| Depression screening using Patient Health Questionnaire Two-Item score (procedure) | 17-Jun-2023 | - |
| Medication reconciliation | 27-May-2023 | - |
| Assessment using AUDIT-C (Alcohol Use Disorders Identification Test - Consumption) | 20-May-2023 | - |
| Screening for domestic abuse | 20-May-2023 | - |
| Depression screening using PHQ-9 (Patient Health Questionnaire 9) score | 15-Oct-2016 | - |
Allergies and Intolerances
| Allergy/Intolerance | Onset Date | Status | Type | Reaction |
|---|---|---|---|---|
| ? | active | ? |
Care Plan
| Active Planned Care / Goals | Start Date | Reason |
|---|---|---|
| Dialysis care plan | 19-Jul-2023 | - |
| Discharge care plan | 18-Apr-2013 | - |
| Lifestyle education regarding hypertension | 08-Jun-1968 | Essential hypertension (disorder) |
|
||
| Immunization Recommendation | Due Date | Reason |
| Vaccine product containing only Influenza virus antigen (medicinal product) | 01-Oct-2025 | Annual seasonal influenza vaccination |
Vital Signs
| Vital Signs | 2025-07-18 | 2025-07-14 |
|---|---|---|
| Weight difference [Mass difference] --pre dialysis - post dialysis | 3 kg | 1.3 kg |
| Pain severity - 0-10 verbal numeric rating [Score] - Reported | 4 {score} | 5 {score} |
Relevant diagnostic tests/laboratory data
| Recent Lab Observations | 08-JUL-2025 | Reference Range | Unit |
|---|---|---|---|
| Glucose [Mass/volume] in Blood | 86.0 | 70 - 140 | mg/dL |
| Urea nitrogen [Mass/volume] in Blood | 14.4 | 7 - 20 | mg/dL |
| Creatinine [Mass/volume] in Blood | 3.4 H | 0.9 - 1.3 | mg/dL |
| Calcium [Mass/volume] in Blood | 8.6 | 8.5 - 10.5 | mg/dL |
| Sodium [Moles/volume] in Blood | 140.8 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Blood | 3.9 | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Blood | 105.9 | 98 - 108 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Blood | 26.7 | 22 - 29 | mmol/L |
| Protein [Mass/volume] in Serum or Plasma | 6.9 | 6 - 8.3 | g/dL |
| Albumin [Mass/volume] in Serum or Plasma | 5.2 | 3.5 - 5.5 | g/dL |
| Globulin [Mass/volume] in Serum by calculation | 2.6 | 2 - 3.5 | g/L |
| Bilirubin.total [Mass/volume] in Serum or Plasma | 1.0 | 0.3 - 1.2 | mg/dL |
| Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 119.9 | 39 - 147 | U/L |
| Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 56.0 | 10 - 63 | U/L |
| Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 16.1 | 10 - 40 | U/L |
| Appearance of Urine | Cloudy urine | ||
| Odor of Urine | Urine smell ammoniacal | ||
| Clarity of Urine | Translucent | ||
| Color of Urine | Brown color | ||
| Glucose [Mass/volume] in Urine by Test strip | 0.8 | 0 - 0.8 | mg/dL |
| Glucose [Presence] in Urine by Test strip | ++ | ||
| Bilirubin.total [Mass/volume] in Urine by Test strip | 0.9 | 0 - 1.9 | mg/dL |
| Bilirubin.total [Presence] in Urine by Test strip | Finding of bilirubin in urine | ||
| Ketones [Mass/volume] in Urine by Test strip | 15.4 H | 0 - 3 | mg/dL |
| Ketones [Presence] in Urine by Test strip | Urine ketone test = +++ | ||
| Specific gravity of Urine by Test strip | 1.0 L | 1.01 - 1.03 | {nominal} |
| pH of Urine by Test strip | 5.1 | 4.5 - 7.5 | pH |
| Protein [Mass/volume] in Urine by Test strip | 447.7 H | 0 - 149 | mg/dL |
| Protein [Presence] in Urine by Test strip | Urine protein test = +++ | ||
| Nitrite [Presence] in Urine by Test strip | Urine nitrite negative | ||
| Hemoglobin [Presence] in Urine by Test strip | Urine blood test = negative | ||
| Leukocyte esterase [Presence] in Urine by Test strip | Urine leukocyte test negative |